Pharma Mar, S.A. (PMRA.F)
Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
80.45+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.9%
The outlook
Pharma Mar, S.A. currently reads as leaning bearish based on below its 50- & 200-day averages, 37% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range37% of the way from its 52-week low to high
Market cap
$1.39B
52-wk high
105.60
52-wk low
65.50
50-day avg
81.81
200-day avg
81.81
Trailing P/E
17.5